Location: Palo Alto, CA
CIK: 0001674712 · Show all filings
Period: Q4 2020 (← Previous) (Next →)
Filing Date: Feb 16, 2021
Total Value: $2.241B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ALXO | ALX Oncology Holdings Inc | 4,220,048 | $364M | 16.2% | $39.31 | +53.0% | Common | 00166B105 |
| ASND | Ascendis Pharma A/S | 1,797,745 | $300M | 13.4% | $112.61 | — | SPONSORED ADR | 04351P101 |
| HRMY | Harmony Biosciences Holdings Inc | 4,534,341 | $164M | 7.3% | $36.46 | +10.7% | Common | 413197104 |
| TARS | Tarsus Pharmaceuticals Inc | 3,245,035 | $134M | 6.0% | $28.48 | 0.0% | Common | 87650L103 |
| — | New Frontier Health Corp | 14,300,000 | $123M | 5.5% | $8.25 | — | Ord Shs | G6461G106 |
| — | Aligos Therapeutics Inc | 3,547,030 | $98.08M | 4.4% | $27.65 | — | Common | 01626L105 |
| — | Genetron Holdings Ltd | 6,339,860 | $88.76M | 4.0% | $12.07 | — | ADS | 37186H100 |
| — | Amyris, Inc | 13,161,847 | $81.27M | 3.6% | $3.12 | — | Common | 03236M200 |
| LEGN | Legend Biotech Corp Sponsored | 2,755,007 | $77.58M | 3.5% | $42.56 | — | SPONSORED ADS | 52490G102 |
| OLMA | Olema Pharmaceuticals Inc | 1,238,575 | $59.55M | 2.7% | $46.89 | 0.0% | Common | 68062P106 |
| — | Iveric Bio Inc | 5,966,527 | $41.23M | 1.8% | $5.10 | — | Common | 46583P102 |
| SVA | Sinovac Biotech Ltd. | 5,900,000 | $38.17M | 1.7% | $6.47 | 0.0% | SHS | P8696W104 |
| — | Passage Bio Inc | 1,487,038 | $38.02M | 1.7% | $15.75 | — | Common | 702712100 |
| CRNX | Crinetics Pharmaceuticals Inc | 2,335,889 | $32.96M | 1.5% | $20.29 | -31.4% | Common | 22663K107 |
| NKTX | Nkarta Inc | 512,225 | $31.49M | 1.4% | $29.47 | +40.9% | Common | 65487U108 |
| — | Sierra Oncology, Inc | 1,917,074 | $30.73M | 1.4% | $10.67 | — | Common | 82640U404 |
| KALV | KalVista Pharmaceuticals Inc. | 1,618,296 | $30.73M | 1.4% | $13.81 | +24.2% | Common | 483497103 |
| ARQT | Arcutis Biotherapeutics Inc | 867,170 | $24.39M | 1.1% | $26.87 | -8.8% | Common | 03969K108 |
| — | Kadmon Holdings Inc | 5,817,459 | $24.14M | 1.1% | $4.19 | — | Common | 48283N106 |
| ZLAB | Zai Lab Ltd ADR | 175,000 | $23.68M | 1.1% | $76.83 | — | ADR | 98887Q104 |
| — | Avadel Pharmaceuticals PLC | 3,526,093 | $23.55M | 1.1% | $7.94 | — | ADR | 05337M104 |
| CLDX | Celldex Therapeutics Inc | 1,291,875 | $22.63M | 1.0% | $4.95 | +263.6% | Common | 15117B202 |
| — | Essa Pharma Inc | 1,893,907 | $22.59M | 1.0% | $7.90 | — | Common | 29668H708 |
| — | Eiger BioPharmaceuticals Inc | 1,791,257 | $22.02M | 1.0% | $6.80 | — | Common | 28249U105 |
| — | Verona Pharma PLC ADR | 3,048,507 | $21.34M | 1.0% | $5.20 | — | ADS | 925050106 |
| — | Zogenix Inc | 1,006,494 | $20.12M | 0.9% | $22.77 | — | Common | 98978L204 |
| — | Chinook Therapeutics Inc | 1,206,266 | $19.13M | 0.9% | $15.86 | — | Common | 16961L106 |
| NVAX | Novavax Inc | 157,487 | $17.56M | 0.8% | $121.82 | -12.7% | Common | 670002401 |
| KURA | Kura Oncology Inc | 525,262 | $17.16M | 0.8% | $14.42 | +143.6% | Common | 50127T109 |
| LRMR | Larimar Therapeutics Inc | 799,662 | $17.12M | 0.8% | $11.65 | +72.1% | Common | 517125100 |
| RCKT | Rocket Pharmaceuticals Inc | 310,584 | $17.03M | 0.8% | $19.80 | +84.1% | Common | 77313F106 |
| — | Akero Therapeutics Inc | 633,426 | $16.34M | 0.7% | $21.65 | — | Common | 00973Y108 |
| IMVT | Immunovant Inc | 347,662 | $16.06M | 0.7% | $23.44 | +97.2% | Common | 45258J102 |
| ARWR | Arrowhead Pharmaceuticals Inc | 205,091 | $15.74M | 0.7% | $40.33 | +58.6% | Common | 04280A100 |
| MREO | Mereo Biopharma Group PLC | 4,220,938 | $15.11M | 0.7% | $2.68 | — | ADS | 589492107 |
| CYTK | Cytokinetics Inc | 700,000 | $14.55M | 0.6% | $23.39 | -21.9% | Common | 23282W605 |
| — | Zymeworks Inc | 286,064 | $13.52M | 0.6% | $35.47 | — | Common | 98985W102 |
| — | Curis Inc | 1,400,000 | $11.47M | 0.5% | $8.19 | — | Common | 231269200 |
| ACRS | Aclaris Therapeutics, Inc. | 1,647,214 | $10.66M | 0.5% | $1.36 | +209.9% | Common | 00461U105 |
| — | Calliditas Therapeutics ADR | 311,030 | $10.46M | 0.5% | $23.20 | — | SPONSORED ADS | 13124Q106 |
| — | Poseida Therapeutics Inc | 926,447 | $10.16M | 0.5% | $8.87 | — | Common | 73730P108 |
| — | Homology Medicines, Inc. | 853,143 | $9.632M | 0.4% | $15.54 | — | Common | 438083107 |
| — | Matinas Biopharma Hldgs Inc | 6,451,612 | $8.774M | 0.4% | $0.60 | — | Common | 576810105 |
| CDXS | Codexis, Inc | 388,144 | $8.473M | 0.4% | $13.98 | +17.8% | Common | 192005106 |
| TXG | 10X Genomics Inc | 58,977 | $8.351M | 0.4% | $145.11 | 0.0% | CL A Common | 88025U109 |
| AUPH | Aurinia Pharmaceuticals Inc. | 500,732 | $6.925M | 0.3% | $17.64 | -17.5% | Common | 05156V102 |
| DYN | Dyne Therapeutics Inc | 315,000 | $6.615M | 0.3% | $21.96 | -9.9% | Common | 26818M108 |
| — | Orchard Therapeutics plc | 1,325,736 | $5.727M | 0.3% | $7.53 | — | ADS | 68570P101 |
| — | Kala Pharmaceuticals, Inc. | 786,883 | $5.335M | 0.2% | $8.79 | — | Common | 483119103 |
| — | Constellation Pharmaceutical | 140,298 | $4.041M | 0.2% | $31.43 | — | Common | 210373106 |
| ATRC | Atricure Inc | 64,573 | $3.595M | 0.2% | $35.95 | +20.3% | Common | 04963C209 |
| — | Cymabay Therapeutics Inc | 585,394 | $3.36M | 0.1% | $2.45 | — | Common | 23257D103 |
| OVID | Ovid Therapeutics Inc | 1,250,000 | $2.888M | 0.1% | $6.69 | -30.3% | Common | 690469101 |
| — | IGM Biosciences Inc | 20,000 | $1.766M | 0.1% | $56.15 | — | Common | 449585108 |
| — | VYNE Therapeutics Inc | 939,513 | $1.484M | 0.1% | $1.66 | — | Common | 92941V100 |
| — | Tricida, Inc. | 174,763 | $1.232M | 0.1% | $22.00 | — | Common | 89610F101 |
| — | Precision Biosciences Inc | 140,255 | $1.17M | 0.1% | $6.03 | — | Common | 74019P108 |
| — | Metacrine Inc | 146,426 | $1.151M | 0.1% | $10.21 | — | Common | 59101E103 |
| RVMD | Revolution Medicines Inc | 16,690 | $661K | 0.0% | $27.68 | +42.8% | Common | 76155X100 |